Your browser doesn't support javascript.
loading
RIPK1 inhibitor Cpd-71 attenuates renal dysfunction in cisplatin-treated mice via attenuating necroptosis, inflammation and oxidative stress.
Wang, Jia-Nan; Liu, Ming-Ming; Wang, Fang; Wei, Biao; Yang, Qin; Cai, Yu-Ting; Chen, Xin; Liu, Xue-Qi; Jiang, Ling; Li, Chao; Hu, Xiao-Wei; Yu, Ju-Tao; Ma, Tao-Tao; Jin, Juan; Wu, Yong-Gui; Li, Jun; Meng, Xiao-Ming.
Afiliación
  • Wang JN; The Key Laboratory of Major Autoimmune Diseases, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical University, Hefei 230032, China.
  • Liu MM; The Key Laboratory of Anti-inflammatory and Immune Medicines, Ministry of Education, Hefei 230032, China.
  • Wang F; The Key Laboratory of Major Autoimmune Diseases, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical University, Hefei 230032, China.
  • Wei B; The Key Laboratory of Anti-inflammatory and Immune Medicines, Ministry of Education, Hefei 230032, China.
  • Yang Q; The Key Laboratory of Major Autoimmune Diseases, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical University, Hefei 230032, China.
  • Cai YT; The Key Laboratory of Anti-inflammatory and Immune Medicines, Ministry of Education, Hefei 230032, China.
  • Chen X; The Key Laboratory of Major Autoimmune Diseases, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical University, Hefei 230032, China.
  • Liu XQ; The Key Laboratory of Anti-inflammatory and Immune Medicines, Ministry of Education, Hefei 230032, China.
  • Jiang L; The Key Laboratory of Major Autoimmune Diseases, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical University, Hefei 230032, China.
  • Li C; The Key Laboratory of Anti-inflammatory and Immune Medicines, Ministry of Education, Hefei 230032, China.
  • Hu XW; The Key Laboratory of Major Autoimmune Diseases, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical University, Hefei 230032, China.
  • Yu JT; The Key Laboratory of Anti-inflammatory and Immune Medicines, Ministry of Education, Hefei 230032, China.
  • Ma TT; Department of Nephrology, The First Affiliated Hospital, Anhui Medical University, Hefei 230032, China.
  • Jin J; The Key Laboratory of Major Autoimmune Diseases, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical University, Hefei 230032, China.
  • Wu YG; The Key Laboratory of Anti-inflammatory and Immune Medicines, Ministry of Education, Hefei 230032, China.
  • Li J; The Key Laboratory of Major Autoimmune Diseases, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical University, Hefei 230032, China.
  • Meng XM; The Key Laboratory of Anti-inflammatory and Immune Medicines, Ministry of Education, Hefei 230032, China.
Clin Sci (Lond) ; 133(14): 1609-1627, 2019 07 31.
Article en En | MEDLINE | ID: mdl-31315969
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Cisplatino / Estrés Oxidativo / Inhibidores de Proteínas Quinasas / Proteína Serina-Treonina Quinasas de Interacción con Receptores / Lesión Renal Aguda / Necroptosis / Antineoplásicos Límite: Animals / Humans / Male Idioma: En Revista: Clin Sci (Lond) Año: 2019 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Cisplatino / Estrés Oxidativo / Inhibidores de Proteínas Quinasas / Proteína Serina-Treonina Quinasas de Interacción con Receptores / Lesión Renal Aguda / Necroptosis / Antineoplásicos Límite: Animals / Humans / Male Idioma: En Revista: Clin Sci (Lond) Año: 2019 Tipo del documento: Article País de afiliación: China